玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)260.00.00.7059.0942.860.5454.2928.571.9455.217.580.8236.6718.8438.26-9.7-6.20.1850.028.570.1863.6438.4626.9514.8819.1421.7515.8820.178.8820.2918.81
23Q3 (19)260.00.00.44-18.52-4.350.35-16.67-7.891.2554.327.760.6-18.920.042.3711.53-7.550.12-14.29-7.690.11-21.43-8.3323.460.21-5.0218.770.21-5.0116.0540.7452.19
23Q2 (18)260.00.00.54100.025.580.42121.0510.530.81200.015.710.7451.0232.1437.99-4.81-21.70.14100.07.690.14100.027.2723.4134.0-5.9818.7333.98-4.2411.0227.5533.14
23Q1 (17)260.00.00.27-44.90.00.19-54.76-29.630.27-83.640.00.49-28.99-2.039.91-2.16-6.20.07-50.0-22.220.07-46.150.017.47-22.771.8113.98-22.761.82-6.99-19.19-22.11
22Q4 (16)260.00.00.496.52-5.770.4210.53-16.01.6542.24-6.250.6915.016.9540.79-11.0-15.930.147.69-17.650.138.330.022.62-8.42-20.6318.10-8.4-20.6111.076.755.26
22Q3 (15)260.00.00.466.98-16.360.380.0-24.01.1665.71-6.450.67.140.045.83-5.54-8.410.130.0-18.750.129.09-14.2924.70-0.8-16.0119.761.02-16.029.5733.1220.37
22Q2 (14)260.00.00.4359.262.380.3840.740.00.70159.261.450.5612.0-6.6748.5214.0312.50.1344.448.330.1157.140.024.9045.112.5719.5642.4610.57-1.625.59-2.63
22Q1 (13)260.00.00.27-48.08-3.570.27-46.00.00.27-84.66-3.570.5-15.252.0442.55-12.30.240.09-47.060.00.07-46.150.017.16-39.79-4.8813.73-39.78-4.85-8.46-26.77-23.00
21Q4 (12)260.00.00.52-5.45-34.180.500.0-35.061.7641.94-28.160.59-1.67-30.5948.52-3.0411.720.176.25-34.620.13-7.14-35.028.50-3.09-5.0622.80-3.1-5.08-0.8312.7515.79
21Q3 (11)260.00.00.5530.953.770.5031.588.71.2479.71-25.30.60.0-7.6950.0416.0211.570.1633.336.670.1427.270.029.4132.9613.5523.5333.0113.5611.2240.4836.16
21Q2 (10)260.00.00.4250.0-4.550.3840.74-9.520.69146.43-38.940.622.453.4543.131.6-8.160.1233.33-14.290.1157.140.022.1222.62-8.7117.6922.59-8.72-9.95-7.28-12.10
21Q1 (9)260.00.00.28-64.56-59.420.27-64.94-63.010.28-88.57-59.420.49-42.35-46.1542.45-2.264.270.09-65.38-60.870.07-65.0-61.1118.04-39.91-25.8814.43-39.93-25.89-5.79-7.751.23
20Q4 (8)260.04.00.7949.06107.890.7767.3983.332.4547.5911.870.8530.7734.9243.43-3.174.30.2673.33100.00.242.86100.030.0215.9158.8424.0215.9358.9721.4234.7638.45
20Q3 (7)260.00.00.5320.4520.450.469.5221.051.6646.9-8.790.6512.076.5644.85-4.499.390.157.1415.380.1427.2727.2725.906.8912.0720.726.9112.06-12.09-7.89-16.48
20Q2 (6)260.00.00.44-36.23-63.030.42-42.47-63.481.1363.77-18.710.58-36.26-58.8746.9615.3521.970.14-39.13-63.160.11-38.89-63.3324.23-0.45-10.3919.38-0.46-10.44.0922.6815.67
20Q1 (5)264.08.330.6981.58331.250.7373.81284.210.69-68.49331.250.9144.4410.9840.71-2.2363.490.2376.92283.330.1880.0350.024.3428.78327.7719.4728.86327.91--0.00
19Q4 (4)25-3.850.00.38-13.640.00.4210.530.02.1920.330.00.633.280.041.641.560.00.130.00.00.1-9.090.018.90-18.220.015.11-18.280.0--0.00
19Q3 (3)260.00.00.44-63.030.00.38-66.960.01.8230.940.00.61-56.740.041.006.490.00.13-65.790.00.11-63.330.023.11-14.530.018.49-14.520.0--0.00
19Q2 (2)268.330.01.19643.750.01.15505.260.01.39768.750.01.4171.950.038.5054.620.00.38533.330.00.3650.00.027.04375.220.021.63375.380.0--0.00
19Q1 (1)240.00.00.160.00.00.190.00.00.160.00.00.820.00.024.900.00.00.060.00.00.040.00.05.690.00.04.550.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/30.1711.05-18.850.48-2.840.48N/A-
2024/20.15-4.98-26.380.318.770.66N/A-
2024/10.16-55.2199.20.1699.20.76N/A因去年1月適逢農曆春節工作天數較少,故營業額較去年同期增加所致。
2023/120.3545.1332.342.6512.210.820.31-
2023/110.2411.03-8.252.299.630.680.37-
2023/100.221.3938.032.0512.240.650.39-
2023/90.223.112.381.839.770.60.3-
2023/80.2123.6-3.721.619.430.750.24-
2023/70.17-53.43-8.341.411.720.760.24-
2023/60.3762.7561.081.2315.210.740.16本月儀器設備銷售額增加
2023/50.2250.6625.350.862.830.580.21-
2023/40.15-27.77-5.190.64-3.260.560.21-
2023/30.210.75-5.670.49-2.650.490.33-
2023/20.2157.1332.840.28-0.340.550.29-
2023/10.08-70.25-39.320.08-39.320.610.26-
2022/120.270.6146.832.363.660.690.22-
2022/110.2767.0314.252.09-0.10.620.24-
2022/100.16-17.44-6.351.82-1.90.570.26-
2022/90.19-11.67-5.541.67-1.450.60.23-
2022/80.2217.675.221.47-0.880.630.22-
2022/70.19-18.17-0.051.25-1.880.590.24-
2022/60.2326.6516.251.07-2.190.560.25-
2022/50.1813.9413.410.84-6.210.560.25-
2022/40.16-28.13-37.030.66-10.40.530.26-
2022/30.2241.94.40.53.190.50.24-
2022/20.1517.4423.960.292.280.470.26-
2022/10.13-28.0-15.140.13-15.140.550.22-
2021/120.18-21.7-41.692.28-23.850.590.19-
2021/110.2336.912.522.09-21.760.610.18-
2021/100.17-16.73-44.21.86-24.020.580.19-
2021/90.2-1.61-15.871.69-21.150.60.22-
2021/80.2111.77-1.471.49-21.820.590.22-
2021/70.19-4.8-6.41.28-24.360.540.24-
2021/60.223.5513.411.09-26.750.60.17-
2021/50.16-36.73-24.120.9-32.00.620.16-
2021/40.2519.1425.380.74-33.470.580.17-
2021/30.2168.47-46.150.49-46.340.490.31-
2021/20.12-19.6-67.690.28-46.490.590.25因去年同期儀器設備銷售額增加,導致本月較去年同期營收減少
2021/10.15-50.5213.190.1513.190.70.22-
2020/120.3137.6655.782.99-13.780.850.17因本月儀器設備銷售額增加,導致本月營收較去年同期增加
2020/110.23-25.49-2.542.68-18.060.780.18-
2020/100.3125.5556.082.45-19.260.760.18因取得客戶之儀器設備訂單於10月完成驗收,導致本月營收增加
2020/90.2415.2329.382.14-24.450.650.32-
2020/80.216.171.591.9-28.260.580.36-
2020/70.215.35-8.041.69-30.80.580.36-
2020/60.17-17.34-7.191.49-33.010.580.26-
2020/50.214.54-72.241.32-35.360.80.19因去年同期客戶新建醫療園區購置相關儀器設備陸續結案所致
2020/40.2-48.83-57.641.11-13.90.970.15因去年同期生技園區實驗動物相關儀器設備需求增加所致
2020/30.391.0890.070.9111.20.910.16因取得客戶之儀器設備訂單於3月完成驗收,導致本月營收增加
2020/20.39181.671.560.52-15.080.720.21-
2020/10.14-31.91-41.910.14-41.910.570.26-
2019/120.2-13.88-34.553.4718.030.630.43-
2019/110.2319.3232.183.2724.170.620.44-
2019/100.24.07-16.173.0323.60.590.46-
2019/90.19-9.51-73.012.8427.770.610.31107年因國家生技研究園區落成,實驗動物相關儀器設備陸續完成驗收,故去年同期認列儀器設備收入增加
2019/80.21-3.93.942.6573.790.610.31隨客戶新建園區購置相關儀器設備陸續結案所致
2019/70.2216.42-3.012.4484.311.150.16隨客戶新建園區購置相關儀器設備陸續結案所致
2019/60.19-75.27-13.392.23101.961.410.14隨客戶新建園區購置相關儀器設備陸續結案所致
2019/50.7559.53296.612.04129.790.0N/A隨客戶新建醫療園區購置相關儀器設備陸續結案所致
2019/40.47129.64173.521.2984.610.0N/A隨客戶生技園區實驗動物相關儀器設備需求增加所致
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)260.01.9417.581.502.742.6512.2939.42-11.00.514.080.6216.980.519.05
2022 (9)260.01.65-6.251.46-9.882.363.5144.29-4.090.49-9.260.53-5.360.42-6.67
2021 (8)260.01.76-28.161.62-31.932.28-23.7546.185.940.54-30.770.56-29.110.45-28.57
2020 (7)264.02.4511.872.388.682.99-13.8343.5920.080.789.860.7914.490.6314.55
2019 (6)258.72.19-3.952.191.863.4718.0336.30-12.930.712.90.694.550.553.77
2018 (5)234.552.28-4.62.15-1.832.94-9.8241.6912.610.690.00.661.540.530.0
2017 (4)2237.52.39-2.852.1923.733.2640.5237.02-11.220.6930.190.6538.30.5332.5
2016 (3)160.02.46-1.21.77-4.322.322.6541.70-4.990.53-3.640.470.00.40.0
2015 (2)166.672.4901.859.472.26-0.4443.896.50.555.770.47-12.960.4-11.11
2014 (1)1500.0001.6902.27041.2100.5200.5400.450

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。